AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Bioventus Inc. Class A Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00D8550C2
14.96▼ 0.08 (-0.53%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
15.04
Day's Range
14.76 – 15.09
52-Week Range
6.47 – 15.89
Volume
383.0K
Avg Volume
420.3K
Share Statistics
Shares Outstanding
Employees
930
Exchange
XNAS
Listed
2021-02-11
Share count as of July 27, 2026

Bioventus Inc. Class A Common Stock (BVS) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Bioventus Inc. Class A Common Stock (BVS)
What is Bioventus Inc. Class A Common Stock's Market Cap?
Bioventus Inc. Class A Common Stock's Market Cap is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's Enterprise Value?
Bioventus Inc. Class A Common Stock's Enterprise Value is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's Trailing P/E?
Bioventus Inc. Class A Common Stock's Trailing P/E is 23.1×, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's Price / Sales?
Bioventus Inc. Class A Common Stock's Price / Sales is 2.2×, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's EV / Revenue?
Bioventus Inc. Class A Common Stock's EV / Revenue is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's EV / EBITDA?
Bioventus Inc. Class A Common Stock's EV / EBITDA is 14.4×, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's Revenue (TTM)?
Bioventus Inc. Class A Common Stock's Revenue (TTM) is $581.8M, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's Net Income (TTM)?
Bioventus Inc. Class A Common Stock's Net Income (TTM) is $54.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's EBITDA?
Bioventus Inc. Class A Common Stock's EBITDA is $103.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bioventus Inc. Class A Common Stock's Diluted EPS (TTM)?
Bioventus Inc. Class A Common Stock's Diluted EPS (TTM) is 0.65, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BVSAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 27, 2026Mar 28, 2026Dec 31, 2025Sep 27, 2025Jun 28, 2025Mar 29, 2025Dec 31, 2024Sep 28, 2024Jun 29, 2024Mar 30, 2024Dec 31, 2023Sep 30, 2023Jul 1, 2023Apr 1, 2023Dec 31, 2022Oct 1, 2022Jul 2, 2022
Net sales
YoY growth+3.8%+6.6%+2.8%-0.2%-2.4%
Cost of sales (including depreciation and amortization of $9,893, $10,603, $19,980 and $20,868, respectively)
Gross profit
% of revenue69.0%68.7%68.9%68.0%69.1%
Selling, general and administrative expense
Research and development expense
Restructuring costs——
Depreciation and amortization
Loss on disposals
Operating income
% of revenue12.5%6.4%12.3%8.1%12.4%
Interest expense, net
Other (income) expense
Other expense
Income before income taxes
Income tax (benefit) expense, net
Net income
% of revenue23.6%3.0%11.0%2.9%6.3%
Income attributable to noncontrolling interest—
Net income attributable to Bioventus Inc.
% of revenue21.8%2.4%9.3%2.3%5.1%
Comprehensive income attributable to noncontrolling interest—
Comprehensive income attributable to Bioventus Inc.
Basic (in dollars per share)
Diluted (in dollars per share)